Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR
Biotech
Intellia cuts 27% of staff as it takes ax to pipeline
Intellia is axing 27% of its staffers as it tosses out pipeline assets to keep the engine running until a potential commercial launch in 2027.
Ben Adams
Jan 10, 2025 4:00am
Gene editor Scribe slims down workforce as it readies for clinic
Jan 8, 2025 5:33pm
Intellia, Alnylam post data on contrasting cardiomyopathy ideas
Nov 18, 2024 7:40am
Beam hits hemoglobin goal in first base editing clinical data
Nov 5, 2024 9:00am
Spanish gene editor licenses DNA-cutting enzymes for up to $43M
Nov 4, 2024 1:46pm
Intellia links in vivo CRISPR therapy to 81% drop in HAE attacks
Oct 24, 2024 8:55am